We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ACTU market cap is 147.07M. The company's latest EPS is USD -1.2669 and P/E is -5.94.
| Quarter End | Mar 2024 | Jun 2024 |
|---|---|---|
| USD (US$) | ||
| Total Revenue | 0 | 0 |
| Operating Income | -7.77M | -5.44M |
| Net Income | -8.3M | -6.57M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -24.97M |
| Net Income | -24.75M |
| Quarter End | Mar 2024 | Jun 2024 |
|---|---|---|
| USD (US$) | ||
| Total Assets | 2.7M | 1.73M |
| Total Liabilities | 16.3M | 21.81M |
| Total Equity | -107.77M | -114.26M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 3M |
| Total Liabilities | 8.44M |
| Total Equity | -99.63M |
| Market Cap | 147.07M |
| Price to Earnings Ratio | -5.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 49.7 |
| Price to Book Ratio | -27 |
| Dividend Yield | - |
| Shares Outstanding | 19.53M |
| Average Volume (1 week) | 133.64k |
| Average Volume (1 Month) | 76.81k |
| 52 Week Change | 50.60% |
| 52 Week High | 10.162 |
| 52 Week Low | 5.00 |
| Spread (Intraday) | 2.03 (26.96%) |
| Company Name | Actuate Therapeutics Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://www.actuatetherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
